Submit your email to push it up the queue
Innoviant by Prescription Solutions, headquartered in the United States, is a prominent player in the pharmacy benefit management (PBM) industry. Founded in 2001, the company has established itself as a leader in optimising prescription drug benefits for employers and health plans across the nation. With a focus on innovative solutions, Innoviant offers a range of services including formulary management, cost containment strategies, and clinical support programmes. Their unique approach combines advanced analytics with personalised service, ensuring clients receive tailored solutions that enhance patient outcomes while controlling costs. Recognised for its commitment to transparency and efficiency, Innoviant has achieved significant milestones in improving medication adherence and reducing overall healthcare expenses. As a trusted partner in the PBM landscape, Innoviant continues to set benchmarks for excellence in prescription management.
How does Innoviant by Prescription Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Innoviant by Prescription Solutions's score of 52 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Innoviant by Prescription Solutions, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. However, the organisation's climate commitments and reduction initiatives are influenced by its parent company, UnitedHealth Group Incorporated, from which it inherits emissions data and sustainability targets. As part of its corporate family, Innoviant aligns with the climate strategies set forth by UnitedHealth Group, which has established science-based targets for emissions reductions. These targets are cascaded down through the corporate structure, reflecting a commitment to addressing climate change and reducing carbon footprints across its operations. While specific reduction targets or achievements for Innoviant are not detailed, the overarching initiatives from UnitedHealth Group indicate a proactive approach to sustainability. The company is engaged in various climate-related initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its emissions reduction strategies. In summary, while Innoviant by Prescription Solutions does not provide specific emissions data or reduction targets, it is committed to climate action through its association with UnitedHealth Group, which sets the framework for its environmental sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Innoviant by Prescription Solutions is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.